Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase.

Xiao L, Salem JE, Clauss S, Hanley A, Bapat A, Hulsmans M, Iwamoto Y, Wojtkiewicz G, Cetinbas M, Schloss MJ, Tedeschi J, Lebrun-Vignes B, Lundby A, Sadreyev RI, Moslehi J, Nahrendorf M, Ellinor PT, Milan DJ
Circulation. 2020 142 (25): 2443-2455

PMID: 33092403 · DOI:10.1161/CIRCULATIONAHA.120.049210

MeSH Terms (20)

Action Potentials Adenine Agammaglobulinaemia Tyrosine Kinase Animals Antineoplastic Agents Atrial Fibrillation Atrial Function, Left CSK Tyrosine-Protein Kinase Databases, Genetic Heart Atria Heart Rate Humans Mice, 129 Strain Mice, Inbred C57BL Mice, Inbred CBA Mice, Knockout Piperidines Protein Kinase Inhibitors Risk Assessment Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links